These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 5882697)
21. [Isoimmunization in the ABO system caused by obstetrician or pregnancy complications (control groups)]. Sauer J; Kulich V Zentralbl Gynakol; 1965 Dec; 87(52):1780-8. PubMed ID: 5885709 [No Abstract] [Full Text] [Related]
22. Rhesus anti-E, anti-c antibodies as a cause of hemolytic disease of the newborn. Nair PM; Sabarinathan K; Jayaprakash PA; Vijayalekshmi Indian Pediatr; 1983 Sep; 20(9):681-4. PubMed ID: 6427106 [No Abstract] [Full Text] [Related]
23. [A case of neonatal hemolytic jaundice due to materno-fetal isoimmunization by factor E]. Marchi AG; Corazza G; Gay A Minerva Pediatr; 1966 Jul; 18(21):1109-10. PubMed ID: 5950344 [No Abstract] [Full Text] [Related]
25. Haemolytic disease of the newborn due to antibodies other than ABO and Rh. Hildebrandt E Can J Med Technol; 1967 Aug; 29(4):132-4. PubMed ID: 6065338 [No Abstract] [Full Text] [Related]
26. [Consideration of 116 pregnancies with feto-maternal immunization. (Maternité de Pellegrin, 19571964)]. Mahon R; Pery G; Soumireu-Mourat J; Van Oort JL Rev Fr Gynecol Obstet; 1966 Oct; 61(10):685-700. PubMed ID: 5983668 [No Abstract] [Full Text] [Related]
27. Successful perinatal management of hydrops fetalis due to hemolytic disease associated with D-- maternal phenotype. Aref K; Boctor FN; Pande S; Uehlinger J; Manning F; Eglowstein M; Mallozzi A; Bebbington M; Weinberg G; Rosen O; Raab C; Brion LP J Perinatol; 2002 Dec; 22(8):667-8. PubMed ID: 12478452 [TBL] [Abstract][Full Text] [Related]
28. Hemolytic disease of the newborn due to alloimmunization as a consequence of multiple transfusions and a delayed hemolytic transfusion reaction in the mother. Kanra T; Erdoğan S; Yurdakök M; Erdem G Turk J Pediatr; 1983; 25(2):129-33. PubMed ID: 6422599 [No Abstract] [Full Text] [Related]
33. [Practical considerations on the obstetrical consequences of Rh iso-immunization]. Chosson J; Mangiapan T Mars Med; 1966; 103(5):397-406. PubMed ID: 5945275 [No Abstract] [Full Text] [Related]
34. [Selective Rh prevention in pregnancy]. Helderweirt G Verh K Acad Geneeskd Belg; 1983; 45(3):261-74. PubMed ID: 6421025 [No Abstract] [Full Text] [Related]
35. Current clinical concepts in hemolytic disease and blood group incompatibility. Cherry SH Prog Clin Biol Res; 1981; 70():205-12. PubMed ID: 6273933 [No Abstract] [Full Text] [Related]
36. Detection of Rh sensitization current practices. Gray MJ Trans N Engl Obstet Gynecol Soc; 1965; 19():63-73. PubMed ID: 5872594 [No Abstract] [Full Text] [Related]
37. Rh hemolytic disease of the newborn: its cause and prevention. Pollack W Prog Clin Biol Res; 1981; 70():185-302. PubMed ID: 6273932 [No Abstract] [Full Text] [Related]
38. Rhesus haemolytic disease of the newborn, complicating a quadruplet pregnancy. Elasoud K; McClure G; Halliday HL; Dornan JC Ulster Med J; 1997 May; 66(1):62-4. PubMed ID: 9185494 [No Abstract] [Full Text] [Related]
39. Hemolytic disease of the newborn: management in pregnancy. Morton BS N S Med Bull; 1965 Oct; 44(10):255-6. PubMed ID: 5212985 [No Abstract] [Full Text] [Related]
40. [Prevention of Rh-sensitization using anti-D-gamma globulin]. Preisler O; Schneider J Med Welt; 1968 Nov; 44():2402-5. PubMed ID: 5305849 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]